These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15067135)

  • 41. Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas.
    Becker AJ; Klein H; Baden T; Aigner L; Normann S; Elger CE; Schramm J; Wiestler OD; Blümcke I
    Acta Neuropathol; 2002 Oct; 104(4):403-8. PubMed ID: 12200628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extraneuronal roles of cyclin-dependent kinase 5.
    Rosales JL; Lee KY
    Bioessays; 2006 Oct; 28(10):1023-34. PubMed ID: 16998837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative roles for Cdk5 in learning and synaptic plasticity.
    Hawasli AH; Bibb JA
    Biotechnol J; 2007 Aug; 2(8):941-8. PubMed ID: 17597494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality.
    Utreras E; Hamada R; Prochazkova M; Terse A; Takahashi S; Ohshima T; Kulkarni AB
    J Neuroinflammation; 2014 Feb; 11():28. PubMed ID: 24495352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclin-dependent kinase 5 is required for control of neuroblast migration in the postnatal subventricular zone.
    Hirota Y; Ohshima T; Kaneko N; Ikeda M; Iwasato T; Kulkarni AB; Mikoshiba K; Okano H; Sawamoto K
    J Neurosci; 2007 Nov; 27(47):12829-38. PubMed ID: 18032654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclin-dependent kinase 5 permits efficient cytoskeletal remodeling--a hypothesis on neuronal migration.
    Xie Z; Samuels BA; Tsai LH
    Cereb Cortex; 2006 Jul; 16 Suppl 1():i64-8. PubMed ID: 16766709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cdk5: a new player at synapses.
    Cheng K; Ip NY
    Neurosignals; 2003; 12(4-5):180-90. PubMed ID: 14673204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Making a neuron: Cdk5 in embryonic and adult neurogenesis.
    Jessberger S; Gage FH; Eisch AJ; Lagace DC
    Trends Neurosci; 2009 Nov; 32(11):575-82. PubMed ID: 19782409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Forebrain-specific deletion of Cdk5 in pyramidal neurons results in mania-like behavior and cognitive impairment.
    Su SC; Rudenko A; Cho S; Tsai LH
    Neurobiol Learn Mem; 2013 Oct; 105():54-62. PubMed ID: 23850563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Cdk5 in drug abuse and plasticity.
    Benavides DR; Bibb JA
    Ann N Y Acad Sci; 2004 Oct; 1025():335-44. PubMed ID: 15542734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin-dependent kinase 5 is required for associative learning.
    Fischer A; Sananbenesi F; Schrick C; Spiess J; Radulovic J
    J Neurosci; 2002 May; 22(9):3700-7. PubMed ID: 11978846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability.
    Price V; Wang L; D'Mello SR
    J Neurosci Res; 2013 Mar; 91(3):407-15. PubMed ID: 23239283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neuronal migration and Cdk5].
    Ohshima T
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(7):796-801. PubMed ID: 19514264
    [No Abstract]   [Full Text] [Related]  

  • 54. Cdk5 in neuroskeletal dynamics.
    Smith D
    Neurosignals; 2003; 12(4-5):239-51. PubMed ID: 14673211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Astroglial PTEN Loss Disrupts Neuronal Lamination by Dysregulating Radial Glia-guided Neuronal Migration.
    Wen Y; Li W; Choudhury GR; He R; Yang T; Liu R; Jin K; Yang SH
    Aging Dis; 2013 Jun; 4(3):113-26. PubMed ID: 23730527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conditional deletion of cyclin-dependent kinase 5 in primary sensory neurons leads to atypical skin lesions.
    Saikkonen B; Pareek TK; Agarwal N; Molinolo A; Kriete M; Kulkarni AB
    Cell Cycle; 2008 Mar; 7(6):750-3. PubMed ID: 18239462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.
    Ahmad M; Krüger BT; Kroll T; Vettorazzi S; Dorn AK; Mengele F; Lee S; Nandi S; Yilmaz D; Stolz M; Tangudu NK; Vázquez DC; Pachmayr J; Cirstea IC; Spasic MV; Ploubidou A; Ignatius A; Tuckermann J
    Bone Res; 2022 Apr; 10(1):33. PubMed ID: 35383146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior.
    Umfress A; Singh S; Ryan KJ; Chakraborti A; Plattner F; Sonawane Y; Mallareddy JR; Acosta EP; Natarajan A; Bibb JA
    Front Pharmacol; 2022; 13():863762. PubMed ID: 35645825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain.
    Cheever TR; Li B; Ervasti JM
    PLoS One; 2012; 7(3):e32970. PubMed ID: 22403730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. At the Fulcrum in Health and Disease: Cdk5 and the Balancing Acts of Neuronal Structure and Physiology.
    McLinden KA; Trunova S; Giniger E
    Brain Disord Ther; 2012 Jul; 2012(Suppl 1):001. PubMed ID: 25364642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.